MYCN gene amplification is a powerful prognostic factor even in infantile neuroblastoma detected by mass screening

MYCN is the most powerful prognostic factor in cases of older children. However, how MYCN is related to the prognosis of infantile cases is not clear. A mass screening program was carried out by measuring urinary catecholamine metabolites (VMA and HVA) from 6-month-old infants. Of 2084 cases detecte...

Descripción completa

Detalles Bibliográficos
Autores principales: Iehara, T, Hosoi, H, Akazawa, K, Matsumoto, Y, Yamamoto, K, Suita, S, Tajiri, T, Kusafuka, T, Hiyama, E, Kaneko, M, Sasaki, F, Sugimoto, T, Sawada, T
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2006
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361271/
https://www.ncbi.nlm.nih.gov/pubmed/16670717
http://dx.doi.org/10.1038/sj.bjc.6603149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361271/
https://www.ncbi.nlm.nih.gov/pubmed/16670717
http://dx.doi.org/10.1038/sj.bjc.6603149

Ejemplares similares